Low Testosterone Raises Atherosclerosis Risk in Diabetic Men
Low total testosterone was associated with increased odds of greater carotid intima-media thickness and odds of endothelial dysfunction.
Low total testosterone was associated with increased odds of greater carotid intima-media thickness and odds of endothelial dysfunction.
Testosterone replacement therapy (TRT) may promote prostate cancer tumor growth.
Low testosterone may increase cardiovascular (CV) risk in middle-aged men with type 2 diabetes.
Testosterone therapy for men who produce little to no hormones does not increase heart attack risk.
When it comes to erectile dysfunction (ED) in middle-aged men, testosterone may not be a key factor.
Joint committee also calls for drug makers to run heart-risk tests on popular ‘Low T’ products.
Expert panel to decide whether prescribing information on testosterone drugs should be changed.
Chemicals found in many household products may reduce androgen levels in both sexes.
This slideshow reviews drug information for NATESTO (testosterone). Table of Contents Slide 3: Indication, Dosage & AdministrationSlide 6: Use in Specific PopulationsSlide 8: Clinical PharmacologySlide 11: Warnings & PrecautionsSlide 16: Clinical Safety & EfficacySlide 20: Drug Storage & Supply
In a study, 74% of men treated with Vogelxo achieved normal testosterone levels within 90 days.